{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:09:08Z","timestamp":1787785748640,"version":"build-2784847793"},"reference-count":61,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Adverse drug reactions (ADRs) are common, often preventable, and a leading cause of morbidity and mortality. Pharmacovigilance (PV) involves detection, assessment, understanding, and prevention of adverse effects or any other drug\u2010related problem. Education of healthcare professionals (HCPs) involved in drug prescription, dispensing and administration is essential to help prevent and mitigate both ADRs and medication errors and has to be focused on 3 pivotal aspects:\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>\n<jats:bold>Awareness<\/jats:bold>: All medicines can produce adverse effects. ADRs should always be considered as part of the differential diagnosis if any new adverse condition, symptoms or signs appear after a drug administration or during or after pharmacological treatment.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>\n<jats:bold>Knowledge<\/jats:bold>: HCPs must have a sound understanding of the most frequently prescribed drugs and over\u2010the\u2010counter medications, factors that make patients more likely to benefit or more susceptible to harm, as well as of causes of medication errors.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>\n<jats:bold>Reporting<\/jats:bold>: HCPs should know how to report ADRs and the role of reporting on regulatory aspects and scientific knowledge.<\/jats:p><\/jats:list-item>\n<\/jats:list>Undergraduate curricula must provide, at a minimum, sufficient skills that warrant the appropriate and safe prescription\/dispensing\/administration of medications in clinical practice, focusing both on therapeutic effects and prevention of harm. Clinical appraisal skills must include ADRs as differential diagnosis, taking accurate medication history, basic individual causality assessment, identification and proper management of ADRs, and informing patients of possible ADRs.<\/jats:p><jats:p>Postgraduate periodic PV training should be mandatory as part of continuing education. Specialised postgraduate education should include advanced contents.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.14179","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T21:30:03Z","timestamp":1574803803000},"page":"779-790","source":"Crossref","is-referenced-by-count":23,"title":["Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content"],"prefix":"10.1111","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2810-1749","authenticated-orcid":false,"given":"Raquel","family":"Herrera Comoglio","sequence":"first","affiliation":[{"name":"Facultad de Ciencias M\u00e9dicas National University of C\u00f3rdoba Argentina  C\u00f3rdoba Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"e_1_2_17_2_1","unstructured":"EMA. Directive 2010\/84\/EU.https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2010:348:0074:0099:EN:PDF accessed on July 2nd 2019"},{"key":"e_1_2_17_3_1","unstructured":"EMA. Guideline on good pharmacovigilance practices (GVP) Annex I \u2010 Definitions (Rev 4) October 9 2017https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdfAccessed on September 9 2019"},{"key":"e_1_2_17_4_1","unstructured":"FDAhttps:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/howdrugsaredevelopedandapproved\/approvalapplications\/investigationalnewdrugindapplication\/ucm362555.htm"},{"key":"e_1_2_17_5_1","unstructured":"WHO. The Importance of Pharmacovigilance \u2010 Safety Monitoring of Medicinal Products \u2010 2002 ISBN 92 4 159015 7"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0571-9"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2010.00602.x"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04186.x"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0216-1"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0681-z"},{"key":"e_1_2_17_11_1","first-page":"727","volume-title":"Manual de Farmacovigilancia","author":"Herrera Comoglio R","year":"2018"},{"key":"e_1_2_17_12_1","unstructured":"WHO. Safety of Medicines \u2010 A Guide to Detecting and Reporting Adverse Drug Reactions \u2010 Why Health Professionals Need to Take Action 2002"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017322"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03064.x"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-016-2170-6"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2441-5"},{"key":"e_1_2_17_19_1","first-page":"2079","article-title":"A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting","volume":"9","author":"Alhawassi TM","year":"2014","journal-title":"Clin Interv Aging"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.9624"},{"key":"e_1_2_17_21_1","first-page":"g6501","article-title":"Kirkham JJ","volume":"349","author":"Saini P","year":"2014","journal-title":"Selective Reporting Bias of Harm Outcomes within Studies: Findings from a Cohort of Systematic Reviews BMJ"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13360"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2411-7"},{"key":"e_1_2_17_24_1","unstructured":"https:\/\/www.gmc-uk.org\/education\/standards-guidance-and-curricula\/projects\/medical-licensing-assessment(accessed on July 28th 2019)"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004221"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0735-y"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019759"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4051"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.07.007"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072761"},{"key":"e_1_2_17_32_1","unstructured":"https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/european-medicines-agency-recommends-suspension-marketing-authorisation-acomplia_en.pdfAccessed on October 20 2019."},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006162.pub2"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61721-8"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003114"},{"key":"e_1_2_17_36_1","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/sibutramine"},{"key":"e_1_2_17_37_1","unstructured":"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-recommends-against-continued-use-meridia-sibutramine"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010128"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2006.00441.x"},{"issue":"2","key":"e_1_2_17_40_1","first-page":"215","article-title":"Valvular heart disease associated with benfluorex","volume":"56","author":"Rafel Ribera J","year":"2003","journal-title":"Rev Esp Cardiol"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00594"},{"key":"e_1_2_17_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02649.x"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01878.x"},{"key":"e_1_2_17_44_1","unstructured":"Education and Training:Technical Series on Safer Primary Care.Geneva:World Health. Organization;2016. Licence: CC BY\u2010NC\u2010SA. ISBN 978\u201392\u20134\u2010151160\u20105 World Health Organization 2016.https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/252271\/9789241511605\u2010eng.pdf;jsessionid=B8930719028657A5FBF0895C55BD029C?sequence=1Accessed on July 9th 2019"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03197.x"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.521"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13491"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02948.x"},{"key":"e_1_2_17_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03414.x"},{"key":"e_1_2_17_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0320-x"},{"key":"e_1_2_17_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12316"},{"key":"e_1_2_17_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1910-3"},{"issue":"1","key":"e_1_2_17_53_1","first-page":"1","article-title":"Prescribing errors in UK hospitals: problems and solutions","volume":"2","author":"Breckenridge RA","year":"2012","journal-title":"Ann Med Surg (Lond)"},{"key":"e_1_2_17_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.12.1363"},{"key":"e_1_2_17_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31188-1"},{"key":"e_1_2_17_56_1","unstructured":"COMMISSION DELEGATED REGULATION (EU) 2016\/161 of 2 October 2015https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32016R0161"},{"key":"e_1_2_17_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0123-x"},{"key":"e_1_2_17_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12700"},{"key":"e_1_2_17_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1976.tb00577.x"},{"key":"e_1_2_17_60_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.t01-1-00700.x"},{"key":"e_1_2_17_61_1","volume-title":"Teaching Pharmacovigilance in University","author":"Herrera Comoglio R.","year":"2017"},{"key":"e_1_2_17_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-015-0521-0"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14179","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14179","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T13:54:03Z","timestamp":1693922043000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1111\/bcp.14179"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14179","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,5]]}}}